Recall proliferation potential of memory CD8+ T cells and antiviral protection

Journal of Immunology

Volumn 175, Issue 7, 2005, Pages 4677-4685

  Bachmann, Martin F ^a   Wolint, Petra ^b   Schwarz, Katrin ^a   Oxenius, Annette ^b  

^a CYTOS BIOTECHNOLOGY AG   (Switzerland)

^b ETH ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; T LYMPHOCYTE ANTIBODY; VIRUS VACCINE;

ANIMAL CELL; ANIMAL TISSUE; ANTIVIRAL ACTIVITY; ARTICLE; CELL BASED GENE THERAPY; CELL POPULATION; CELL PROLIFERATION; CELL PROTECTION; CELL SEPARATION; CELL SUBPOPULATION; CONTROLLED STUDY; CYTOLYSIS; EFFECTOR CELL; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MEMORY CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; VACCINE PRODUCTION; VACCINIA VIRUS; VIRUS INFECTION; VIRUS REPLICATION;

EID: 25444499685     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.175.7.4677     Document Type: Article

References (57)

1. Ramshaw, I. A., A. J. Ramsay, G. Karupiah, M. S. Rolph, S. Mahalingam, and J. C. Ruby. 1997. Cytokines and immunity to viral infections. Immunol. Rev. 159: 119-135.
2. Kägi, D., B. Lederman, K. Bürki, R. M. Zinkernagel, and H. Hengartner. 1996. Molecular mechanisms of lymphocyte-mediated cytotoxicity and their role in immunological protection and pathogenesis in vivo. Annu. Rev. Immunol. 14: 207-232.
3. Lowin, B., M. C. Peitsch, and J. Tschopp. 1995. Perform and granzymes: crucial effector molecules in cytolytic T lymphocyte and natural killer cell-mediated cytotoxicity. Curr. Top Microbiol. Immunol. 198: 1-24.
4. Zinkernagel, R. M., M. F. Bachmann, T. M. Kündig, S. Oehen, H. Pircher, and H. Hengartner. 1996. On immunological memory. Annu. Rev. Immunol. 14: 333.
5. Ahmed, R., and D. Gray. 1996. Immunological memory and protective immunity: understanding their relation. Science 272: 54-60.
6. + T-cell memory to viruses. Curr. Opin. Immunol 6: 545-552.
7. Sallusto, F., and A. Lanzavecchia. 2001. Exploring pathways for memory T cell generation. J. Clin. Invest. 108: 805-806.
8. Murali-Krishna, K., J. D. Altman, M. Suresh, D. J. Sourdive, A. J. Zajac, J. D. Miller, J. Slansky, and R. Ahmed. 1998. Counting antigen-specific CD8 T cells: a reevaluation of bystander activation during viral infection. Immunity 8: 177-187.
9. Gallimore, A., A. Glithero, A. Godkin, A. C. Tissot, A. Plückthun, T. Elliott, H. Hengartner, and R. M. Zinkernagel. 1998. Induction and exhaustion of lymphocytic choriomeningitis virus-specific cytotoxic T lymphocytes visualized using soluble tetrameric major histocompatibility complex class-1 peptide complexes. J. Exp. Med. 187: 1383-1393.
10. Kaech, S. M., J. T. Tan, E. J. Wherry, B. T. Konieczny, C. D. Surh, and R. Ahmed. 2003. Selective expression of the interleukin 7 receptor identifies effector CD8 T cells that give rise to long-lived memory cells. Nat. Immunol. 4: 1191-1198.
11. + memory T cell subsets. Proc. Natl. Acad. Sci. USA 101: 5610-5615.
12. Madakamutil, L. T., U. Christen, C. J. Lena, Y. Wang-Zhu, A. Attinger, M. Sundarrajan, W. Ellmeier, M. G. von Herrath, P. Jensen, D. R. Littman, and H. Cheroutre. 2004. CD8αα-mediated survival and differentiation of CD8 memory T cell precursors. Science 304: 590-593.
13. Liu, N., T. Phillips, M. Zhang, Y. Wang, J. T. Opferman, R. Shah, and P. G. Ashton-Rickardt. 2004. Serine protease inhibitor 2A is a protective factor for memory T cell development. Nat. Immunol. 5: 919-926.
14. Sun, J. C., and M. J. Bevan. 2003. Defective CD8 T cell memory following acute infection without CD4 T cell help. Science 300: 339-342.
15. Shedlock, D. J., and H. Shen. 2003. Requirement for CD4 T cell help in generating functional CDS T cell memory. Science 300: 337-339.
16. + T lymphocytes. Nature 421: 852-856.
17. + T cells. J. Immunol. 173: 2217-2221.
18. Bachmann, M. F., T. M. Kundig, H. Hengartner, and R. M. Zinkernagel. 1997. Protection against immunopathological consequences of a viral infection by activated but not resting cytotoxic T cells: T cell memory without "memory T cells"? Proc. Natl. Acad. Sci. USA 94: 640-645.
19. Sallusto, F., D. Lenig, R. Forster, M. Lipp, and A. Lanzavecchia. 1999. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 401: 708-712.
20. + T cells persist in the lungs following recovery from respiratory virus infections. J. Immunol. 166: 1813-1822.
21. Masopust, D., V. Vezys, E. J. Usherwood, L. S. Cauley, S. Olson, A. L. Marzo, R. L. Ward, D. L. Woodland, and L. Lefrancois. 2004. Activated primary and memory CD8 T cells migrate to nonlymphoid tissues regardless of site of activation or tissue of origin. J. Immunol. 172: 4875-4882.
22. + T cells. Proc. Natl. Acad. Sci. USA 98: 6313-6318.
23. + memory T cells in nonlymphoid tissues express a highly activated phenotype. J. Immunol. 169: 6655-6658.
24. Wherry, E. J., V. Teichgraber, T. C. Becker, D. Masopust, S. M. Kaech, R. Antia, U. H. von Andrian, and R. Ahmed. 2003. Lineage relationship and protective immunity of memory CD8 T cell subsets. Nat. Immunol. 4: 225-234.
25. - memory T cells do not differ in immediate effector cell function. J. Immunol. 169: 638-641.
26. + memory cells in humans defined by HLA and CC chemokine ligand 19 tetramers. J. Immunol. 170: 2461-2468.
27. + T cells. J. Exp. Med. 199: 925-936.
28. Harris, N. L., V. Watt, F. Ronchese, and G. Le Gros. 2002. Differential T cell function and fate in lymph node and nonlymphoid tissues. J. Exp. Med. 195: 317-326.
29. + memory T cell subsets in persistent EBV infection are differentiated by migratory receptor expression. Eur. J. Immunol. 30: 1823-1829.
30. Lefrancois, L., and D. Masopust. 2002. T cell immunity in lymphoid and nonlymphoid tissues. Curr. Opin. Immunol. 14: 503-508.
31. Masopust, D., V. Vezys, A. L. Marzo, and L. Lefrancois. 2001. Preferential localization of effector memory cells in nonlymphoid tissue. Science 291: 2413-2417.
32. + T cells that preferentially respond to recall antigen. J. Immunol. 170: 28-32.
33. + T cells in the lung airways depends on proliferation. J. Immunol. 169: 4976-4981.
34. + T cells in the lung airways retain the potential to mediate recall responses. J. Immunol. 171: 3338-3342.
35. Roberts, A. D., K. H. Ely, and D. L. Woodland. 2005. Differential contributions of central and effector memory T cells to recall responses. J. Exp. Med. 202: 123-133.
36. + T cells after acute infection. Nat. Immunol. 5: 927-933.
37. Marzo, A. L., V. Vezys, K. D. Klonowski, S. J. Lee, G. Muralimohan, M. Moore, D. F. Tough, and L. Lefrancois. 2004. Fully functional memory CD8 T cells in the absence of CD4 T cells. J. Immunol. 173: 969-975.
38. Zinkernagel, R. M. 2003. On natural and artificial vaccinations. Annu. Rev. Immunol. 21: 515-546.
39. + T cell populations after murine cytomegalovirus infection. Eur. J. Immunol. 35: 1113-1123.
40. Wherry, E. J., D. L. Barber, S. M. Kaech, J. N. Blattman, and R. Ahmed. 2004. Antigen-independent memory CD8 T cells do not develop during chronic viral infection. Proc. Natl. Acad. Sci. USA 101: 16004-16009.
41. Zaph, C., J. Uzonna, S. M. Beverley, and P. Scott. 2004. Central memory T cells mediate long-term immunity to Leishmania major in the absence of persistent parasites. Nat. Med. 10: 1104-1110.
42. Pircher, H. P., D. Moskophidis, U. Rohrer, K. Bürki, H. Hengartner, and R. M. Zinkernagel. 1990. Viral escape by selection of cytotoxic T cell-resistant virus variants in vivo. Nature 346: 629-633.
43. Oxenius, A., M. F. Bachmann, R. M. Zinkernagel, and H. Hengartner. 1998. Virus-specific MHC-cIass II-restricted TCR-transgenic mice: effects on humoral and cellular immune responses after viral infection. Eur. J. Immunol. 28: 390-400.
44. Storni, T., C. Ruedl, K. Schwarz, R. A. Schwendener, W. A. Renner, and M. F. Bachmann. 2004. Nonmethylated CG motifs packaged into virus-like particles induce protective cytotoxic T cell responses in the absence of systemic side effects. J. Immunol. 172: 1777-1785.
45. Altman, J. D., P. A. H. Moss, P. J. R. Goulder, D. H. Barouch, M. G. McHeyzer-Williams, J. I. Bell, A. J. McMichael, and M. M. Davis. 1996. Phenotypic analysis of antigen-specific T lymphocytes, [published erratum appears in 1998 Science 280: 1821.] Science 274: 94-96.
46. Battegay, M., S. Cooper, A. Althage, J. Baenziger, H. Hengartner, and R. M. Zinkernagel. 1991. Quantification of lymphocytic choriomeningitis virus with an immunological focus assay in 24 or 96 well plates. J. Virol. Methods 33: 191-198.
47. Bachmann, M. F., T. M. Kundig, G. Freer, Y. Li, C. Y. Kang, D. H. Bishop, H. Hengartner, and R. M. Zinkernagel. 1994. Induction of protective cytotoxic T cells with viral proteins. Eur. J. Immunol. 24: 2228-2236.
48. Bourgeois, C., H. Veiga-Fernandes, A. M. Joret, B. Rocha, and C. Tanchot. 2002. CD8 lethargy in the absence of CD4 help. Eur. J. Immunol. 32: 2199-2207.
49. Schwarz, K., E. Meijerink, D. E. Speiser, A. C. Tissot, I. Cielens, R. Renhof, A. Dishlers, P. Pumpens, and M. F. Bachmann. 2005. Efficient homologous prime-boost strategies for T cell vaccination based on virus-like particles. Eur. J. Immunol. 35: 816-821.
50. + T cell memory. Science 297: 2060-2063.
51. Kundig, T. M., M. F. Bachmann, S. Oehen, U. W. Hoffmann, J. J. Simard, C. P. Kalberer, H. Pircher, P. S. Ohashi, H. Hengartner, and R. M. Zinkernagel. 1996. On the role of antigen in maintaining cytotoxic T-cell memory. Proc. Natl. Acad. Sci. USA 93: 9716-9723.
52. Cerwenka, A., T. M. Morgan, and R. W. Dutton. 1999. Naive, effector, and memory CD8 T cells in protection against pulmonary influenza virus infection: homing properties rather than initial frequencies are crucial. J. Immunol. 163: 5535-5543.
53. 1 integrin VLA-1 regulates CD8 T cell-mediated immune protection against heterologous influenza infection. Immunity 20: 167-179.
54. + T cells correlating with cytotoxic activity in vitro are more efficient in antivaccinia virus protection than CD4-dependent interleukins. J. Immunol. 146: 4301-4307.
55. + T cell subsets identified by expression of IL-7 receptor α and CD62 ligand. J. Immunol. 175: 4686-4696.
56. Barouch, D. H., S. Santra, J. E. Schmitz, M. J. Kuroda, T. M. Fu, W. Wagner, M. Bilska, A. Craiu, X. X. Zheng, G. R. Krivulka, et al. 2000. Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination. Science 290: 486-492.
57. Barouch, D. H., S. Santra, M. J. Kuroda, J. E. Schmitz, R. Plishka, A. Buckler-White, A. E. Gaitan, R. Zin, J. H. Nam, L. S. Wyatt, et al. 2001. Reduction of simian-human immunodeficiency virus 89.6P viremia in rhesus monkeys by recombinant modified vaccinia virus Ankara vaccination. J. Virol. 75: 5151-5158.